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H
uman immunodeficiency virus continues to devas-
tate sub-Saharan Africa (Figure 1).1 Despite evidence 
to the contrary,2 many physicians still question whether 
AIDS treatment is even possible in resource-limited set-
tings. Rural HIV-positive Africans are often tormented 
by fear of discrimination, fear of HIV-related stigma, and 
confusion from conflicting traditional and faith-based 
beliefs.3 Within this context, stories of survival—success-
ful antiretroviral treatment (ART)—are powerful motiva-
tors for physicians, patients, and communities. 
Differential access to services, diagnoses and screen-
ing, practitioner factors, and patient adherence can 
affect the effectiveness of our clinical interventions.4 
Success stories are emerging, however, as Médecins 
Sans Frontières (MSF) (Doctors Without Borders) and 
other medical organizations integrate HIV and AIDS 
care  into  basic  health  care  programs  in  resource-
limited settings. We present this case report to raise 
awareness of integrated HIV care,5 which has impli-
cations for family physicians working internationally 
and for those working with African refugees in Canada. 
This case outlines the process of diagnosis and man-
agement of a patient who presented to a basic health 
program that had integrated HIV and AIDS care in a 
rural village in the Republic of Congo (ROC). It high-
lights the central role of psychosocial counseling and 
simplified single-pill ART, together with management 
protocols that integrate HIV care.  
Case description
Claire*  arrived  at  the  Kindamba  hospital  on  her 
mother’s back. She had a headache and was cachec-
tic, feverish, and unable to stand. Claire, who was 
a 23-year-old single mother of 2 small children, had 
only a few years of primary school education and 
managed to generate money for her family with a 
small vegetable garden. On examination she weighed 
38 kg (body mass index of 14.8 kg/m2) and had a left 
hemiplegia as well as a temperature of 40°C. There 
were no clinical signs of meningismus, lymphade-
nopathy, or oral or genital lesions, and examination 
of the lungs found nothing remarkable.   This article has been peer reviewed.
Cet article a fait l’objet d’une révision par des pairs.
Can Fam Physician 2010;56:434-7 *The patient’s name has been changed.
Figure 1. Prevalence of HIV (2004): Territory size shows the proportion of worldwide HIV prevalence.
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Context 
The leading causes of morbidity and mortality in the 
ROC  are  malaria,  respiratory  tract  infections,  and 
diarrheal diseases.6,7 Each of these diseases can be 
aggravated by HIV and AIDS, which in the ROC has 
an estimated prevalence of 3.3% to 7.5%.8 The pub-
lic health system operates with a minimal budget. In 
this conflict-affected setting, the rural Kindamba hos-
pital—serving a population of 15 000—was supported 
by an MSF basic health program, with integrated HIV 
treatment capacity. The program employed 2 doctors, 
3 nurses, 2 midwives, and 2 psychologists, and also 
had medical logistic and basic laboratory support. The 
Congolese medical team had participated in a 4-week 
training program in the management of HIV-related ill-
ness, receiving international mentorship from experi-
enced MSF AIDS advisors.5 
Clinical investigations
Investigations  revealed  the  following:  a  hemoglo-
bin level of 70 g/L, a normal white blood cell count, 
negative results of a thick smear for malaria, a positive 
rapid plasma reagin test result for syphilis antibody, a 
positive test result for hepatitis B surface antigen, and a 
negative  pregnancy test result. Owing to the presence 
of focal neurological signs, a lumbar puncture was not 
performed, and x-ray facilities were not available in the 
project.
Claire was admitted to hospital. She received high-
dose cotrimoxazole (ie, 800 mg of sulfamethoxazole 
and 160 mg of trimethoprim orally twice daily) for pre-
sumed cerebral toxoplasmosis and was treated for syph-
ilis with benzathine penicillin G (2.4 million units weekly 
for 3 weeks). Her condition improved remarkably over 1 
week and she began to walk again. A team psychologist 
offered HIV counseling and testing. She had a positive 
result with rapid HIV antibody testing. The team referred 
her to a nearby sister hospital, where her CD4 cell count 
was measured at 50 cells/mm3.
After several sessions of in-depth counseling to com-
municate the nature of HIV, the availability of effective 
AIDS treatment, and practical support on how to incor-
porate biomedical treatment approaches to HIV with 
traditional and faith-based approaches, Claire accepted 
her HIV-positive status. She disclosed the results to her 
mother, who remained supportive, and Claire expressed 
an interest in taking ART. She was diagnosed with World 
Health Organization (WHO) clinical stage IV disease and 
was therefore eligible for ART according to the MSF and 
WHO guidelines.9   
Treatment
The medical team prescribed ART, Triomune 30 (ie, a 
generic, single, fixed-dose combination pill, including 
30 mg of stavudine, 150 mg of lamivudine, and 200 mg 
of nevirapine). The team also provided a nutritional 
biscuit  supplement  to  address  her  low  body  mass 
index. She continued to take the high-dose cotrimoxa-
zole for 6 weeks, after which she began a prophylactic 
dose (ie, 800 mg of sulfamethoxazole and 160 mg of 
trimethoprim once daily).   
Within 2 months Claire gained 10 kg and was dis-
charged home in stable condition. She was well-
groomed  and  punctual  when  she  arrived  at  all 
follow-up medical appointments (which occurred 
monthly for 3 months after ART initiation, and every 
3 months thereafter). To minimize the risk of medi-
cation interruption if acute insecurity developed 
from war-related conflict, she was given an addi-
tional 1-week security supply of antiretrovirals and 
cotrimoxazole. At her 6-month follow-up appoint-
ment,  Claire’s  CD4  cell  count  had  increased  to 
374 cells/mm3 and she had gained 20 kg in weight. 
After 12 months taking ART, her CD4 cell count rose 
to 437 cells/mm3.  
Discussion
This case demonstrates a common presentation, as well 
as a common diagnostic, counseling, treatment, and 
monitoring approach, of a rural patient from the ROC 
with HIV-related illness. Claire was 1 of 236 patients 436  Canadian Family Physician • Le Médecin de famille canadien  Vol 56: may • mai 2010
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successfully treated within the first 
2 years of integrated HIV care in the 
Pool Region. Cerebral toxoplasmo-
sis,  Claire’s  presenting  diagnosis, 
is a common HIV-related illness in 
the Kindamba area, and it typically 
responds within a week to high-dose 
cotrimoxazole treatment.  
This  report  highlights  the  criti-
cal role of counseling to reduce fear 
and  increasing  treatment  literacy 
in order to help achieve the greater 
than 95% adherence rates required 
for sustained ART success.10,11 Other 
key enablers included training that 
provided initially reluctant rural phy-
sicians  the  awareness  and  knowl-
edge needed to consider HIV-related 
opportunistic infections. The accessi-
bility of point-of-care HIV testing, the 
simplified but effective ART manage-
ment protocols, and the drug effect 
and disease monitoring within the 
community  were  also  factors  that 
played a role in enabling Claire’s care.
Claire’s  20-kg  weight  gain,  her 
improved  grooming,  her  renewed 
ability to walk, and the substantial 
increase in her CD4 cell count dem-
onstrated  the  effectiveness  of  the 
ART  and  served  as  powerful  testi-
mony to other patients and the rural 
hospital staff. Demonstrating value, 
to both patients and health care pro-
viders,  is  often  cited  as  an  impor-
tant ingredient in the dissemination 
of new innovations.12 The CD4 cell 
counts  are  a  simple  way  to  deter-
mine the level of immunosuppres-
sion and the treatment effect of ART. 
With basic training, mentorship, and 
allied health counselor support, phy-
sicians can potentially enter into the 
delivery of HIV care.  
Despite  successes,  HIV  pro-
grams  face  further  challenges  in 
the future. These include the sus-
tainability  of  quality  care  after 
international  organizations  leave, 
the need to address both the pre-
vention of perinatal HIV transmis-
sion and treatment of children, and 
the eventual need for more costly 
and complex second-line regimens 
for  those  failing  first-line  ARTs. 
Even  if  HIV  care  programs  are 
not  successfully  sustained  by  the 
Ministry of Health, we argue that 
capacity building through the train-
ing  of  national  health  personnel, 
the design, promotion, and imple-
mentation of chronic disease man-
agement approaches and education, 
as  well  as  empowerment  of  the 
local HIV-infected or HIV-affected 
population are all valuable for the 
development of future services for 
patients with HIV. 
Conclusion
We hope this case report will sensi-
tize family doctors to the issues of 
HIV in Africa and possibly inspire 
them to contribute to medical HIV-
related  work.  Family  physicians 
who are interested in helping might 
also  consider  donating  to  repu-
table  nongovernmental  organiza-
tions  or  foundations  that  address 
AIDS in Africa (eg, Stephen Lewis 
Foundation, Dignitas International, 
and MSF).   
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Editor’s kEy points
•	 The management of HIV can be effectively inte-
grated into basic health programs in sub-Saharan 
Africa.
•	 Psychosocial  counseling  is  critical  to  helping 
patients integrate biomedical beliefs (ie, antiretro-
viral treatment [ART]) within the context of tradi-
tional and faith-based beliefs. 
•	 Key elements for effective HIV care include fixed-
dose ART, treatment protocols, adherence coun-
seling, and monitoring. 
•	 Demonstrating the power of ART can transform 
reluctant medical staff and community members into 
motivated learners and advocates for HIV care.
points dE rEpÈrE dU rÉdACtEUr
•	 La prise en charge du VIH peut être efficacement 
incorporée dans les programmes de santé de base en 
Afrique subsaharienne. 
•	 Il est essentiel d’offrir du counseling psychosocial 
pour aider les patients à intégrer les croyances bio-
médicales (p. ex. le traitement antirétroviral [ARV]) 
dans le contexte de leurs croyances traditionnelles et 
religieuses. 
•	 Pour des soins efficaces dans les cas de VIH, les 
principaux éléments sont les suivants: traitement à 
doses fixes d’ARV, protocoles de traitement, counse-
ling sur la conformité au traitement et surveillance.  
•	 La démonstration du pouvoir des ARV peut trans-
former un personnel médical et des membres de la 
communauté récalcitrants en apprenants motivés et 
en défenseurs des soins pour le VIH. 